A M Rubinstein - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A M Rubinstein

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Aesthetic Plastic Surgery|November 1, 2013

The "Unpleasant" smileA S Kostianovsky, A M Rubinstein

Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000

Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibodyL Weiss, S Slavin, S Reich, et al.

NPJ Precision Oncology|June 11, 2021

Overcoming resistance to BRAF<sup>V600E</sup> inhibition in melanoma by deciphering and targeting personalized protein network alterationsS Vasudevan, E Flashner-Abramson, Heba Alkhatib, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Aesthetic Plastic Surgery|November 1, 2013

The "Unpleasant" smileA S Kostianovsky, A M Rubinstein

Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000

Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibodyL Weiss, S Slavin, S Reich, et al.

NPJ Precision Oncology|June 11, 2021

Overcoming resistance to BRAF<sup>V600E</sup> inhibition in melanoma by deciphering and targeting personalized protein network alterationsS Vasudevan, E Flashner-Abramson, Heba Alkhatib, et al.

Pageof 1